GATE



Trademark Coverage

No Class Specified

pharmaceuticals for the treatment of Wilson’s disease and Tourette’s syndrome; pharmaceuticals for lowering plasma triglycerides; pharmaceuticals for treatment of obesity

Owner
Timeline
  • Aug 08
    2013
    Notice Of Acceptance Of SEC 8 & 9 E Mailed
  • Aug 08
    2013
    Registered And Renewed (First Renewal 10 Yrs)
  • Aug 08
    2013
    Registered SEC 8 (10 Yr) ACCEPTED/SEC 9 Granted
  • Aug 08
    2013
    Case Assigned To Post Registration Paralegal
  • Jul 24
    2013
    TEAS Section 8 & 9 Received
  • Jul 24
    2013
    TEAS Change Of Correspondence Received
  • Jun 18
    2013
    Attorney Revoked And/Or Appointed
  • Jun 18
    2013
    TEAS Revoke/Appoint Attorney Received
  • Nov 10
    2009
    Attorney Revoked And/Or Appointed
  • Nov 10
    2009
    TEAS Revoke/Appoint Attorney Received
  • Jul 16
    2009
    Registered SEC 8 (6 Yr) Accepted & SEC 15 ACK
  • Jul 06
    2009
    Assigned To Paralegal
  • Jul 02
    2009
    TEAS Section 8 & 15 Received
  • Jul 29
    2003
    Registered Principal Register
  • May 06
    2003
    Published For Opposition
  • Apr 16
    2003
    Notice Of Publication
  • Mar 16
    2003
    Approved For PUB Principal Register
  • Mar 14
    2003
    Assigned To Examiner